Omada Health shares surged 10.5% to $20.89 in the last trading session on higher-than-average volume. The gain was fueled by optimism following the company's presentation at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, where it highlighted crossing 1 million total members for the first time since inception, with strong enrollment across GLP-1 services and cardiometabolic offerings. The company is expected to report quarterly earnings of $0.05 per share, a year-over-year increase of 155.6%, on revenues of $80.93 million, up 31.9%. Despite the price jump, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days, and the stock carries a Zacks Rank of 3, or Hold.
Omada Health, Inc. Common StockCrossed 1 million total members with strong enrollment in GLP-1 and cardiometabolic services
